|
|
 |
|
DEPO: Depomed Inc - Stock News |
Enter Ticker:
|
|
| Nov 23, 2009 |
Depomed (DEPO) Bearish Technical Alert - Trend Down 20.9% |
| Nov 19, 2009 |
BiomedReports: News and FDA Updates for Depomed (NASDAQ:DEPO), Exelixis (Nasdaq:EXEL), PPD (NASDAQ:PPDI) |
| Nov 18, 2009 |
Depomed Promotes William Callahan to Vice President of Operations |
| Nov 17, 2009 |
Depomed Down 22% Since SmarTrend's Sell Recommendation |
| Nov 16, 2009 |
Depomed Ranked #13 on Deloitte's Technology Fast 500(TM) |
| Nov 10, 2009 |
Stock research report available on Depomed (NASDAQ:DEPO) from SmarTrend Analytics |
| Nov 10, 2009 |
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R) |
| Nov 03, 2009 |
Depomed to Present at Merriman Curhan Ford's Investor Summit 2009 |
| Nov 02, 2009 |
Depomed Down 26% Since SmarTrend's Sell Recommendation |
| Oct 30, 2009 |
BiomedReports: News and FDA Updates for Depomed (NASDAQ:DEPO), Perrigo (Nasdaq:PRGO), Transgenomic (OTC:TBIO) |
| Oct 27, 2009 |
Depomed Down 20.1% Since SmarTrend's Sell Recommendation |
| Oct 22, 2009 |
Depomed, Inc. to Announce Third Quarter 2009 Financial Results on October 29, 2009 |
| Oct 22, 2009 |
Depomed Announces Delivery of First Formulation to Covidien and Receipt of $500,000 Milestone Payment |
| Oct 19, 2009 |
Depomed (DEPO) Bearish Technical Alert - Trend Down 14.5% |
| Oct 13, 2009 |
BUYINS.NET: DepoMed (DEPO) Daily Short Sale Trading Volume Through 10-12-09 |
| |
| ZACKS COMMENTARY FOR DEPO |
|
|
|